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Dr Christopher A. Caldarone (Toronto, Ontario, Canada).
Dr Kitahori, that was a very nice presentation.
Dr Kitahori has described a series of high-risk hypoplastic left
heart syndrome (HLHS) patients treated with bilateral pulmonary
artery (PA) banding (bPAB). He has tried to clarify the relationship
between the geometry of the PA band and arterial oxygen satura-
tion (SaO2) at the second-stage procedure.
In a fully grown neonate, this might not be as important because
numerous clinical reports have described the use of 3.5-mm diam-
eter polytetrafluoroethylene shunts wrapped around the branch
PAs.We have used this technique at the Hospital for Sick Children,
and it seems towork well. We have typically evaluated the banding
at the end of the procedure with angiography, but our approach has
been very subjective. Dr Kitahori is to be applauded for trying to
create some objective criteria for how to define these bands.
This is even more important in the small neonates in whom the
degree of banding is very difficult to adjust precisely. Small
changes in the circumference of a band will result in large changes
in the internal diameter and, consequently, even greater changes in
the resistance across the band.
We have competing interests in these small infants in that we
want the bands tight enough to restrict pulmonary blood flow, pre-
vent volume overload, and maintain adequate diastolic pressures,
and, at the same time, wewant the bands loose enough to allow ad-
equate SaO2 at banding and adequate SaO2 to be able to persist to
the time of the second-stage procedure, a difficult balancing act in
these very small infants. For that reason, this is an important con-
tribution because you are trying to define the relationship between
the geometry at banding and the subsequent SaO2.
As we discussed, I think the model would benefit if you could
create a model that was derived solely from variables determined
at bPAB. However, putting that aside, it would be a very valuable
addition and perhaps something you could study in the future.
With regard to questions regarding the presented data, I have 3.
First, could you describewhat clinical parameters are used when
the bands were constructed in your series. Each band reallymust be
assessed individually. Simply using the systemic SaO2 would be
inappropriate, because, as you know, you could have complete oc-
clusion of 1 pulmonary artery and a very loose band on the other
and have seemingly appropriate systemic SaO2. Thus, each band
really should be evaluated independently. How do you interrogate
the bands and determine the appropriate tightness of the bands?
Dr Kitahori. Thank you, Dr Caldarone.
The infants’ body weight varies so much, from 1.5 to 4 kg. This
is a very large difference. We thought the PA band should be ad-
justed to the suitable size, because the PA band on the main PA
trunk is adjusted according to Trusler’s rule. Mainly, we have mon-
itored the SaO2 in the operating room. In addition, we usually use
transesophageal echocardiography (TEE). TEE is also useful. Us-
ing TEE, we can see the pulmonary venous (PV) return well, and
we can check the balance of the right and left PV return. Also, the
bilateral PV return should be equivalent after bPAB. If the PV re-
turn of 1 side exceeds the other too much, the PA band should be
readjusted to be tighter or the other looser. However, we do not yet
have any clear criteria for the evaluation using TEE, such as the
exact value of the flow velocity of the PA band.We just see the bal-
ance. Although our TEE probe is the smallest available, it is some-1090 The Journal of Thoracic and Cardiovascular Surtimes difficult to measure the blood flow velocity in the PA
precisely, because the echoprobe direction does not always fit
the blood flow direction. In such cases, we could over- or underes-
timate the flow velocity. Thus, evaluation using TEE is a future
work for us—how to use TEE for the measurement of a precise
evaluation of the PA band.
Dr Caldarone. All right. Well, assuming that you have per-
fectly symmetric pulmonary artery bands, what is the appropriate
SaO2 at PA banding?
DrKitahori.We adjust the PA band with help of TEE. Our goal
for SaO2 is about 80% and 85% at maximum. In my opinion, the
SaO2 in the operating room should be in the slightly lower range,
meaning 80%, because the SaO2 usually gradually increases a little
bit after surgery. As you said, we want to reduce the volume over-
load as much as possible, but we have to keep the SaO2 at a good
level. Thus, the SaO2 must not be going to be quite low, which
would result in a lethal level. Thus, I think 80% would be good.
Dr Caldarone. My third question. In the manuscript you re-
ported that you administer prostaglandin to the infants from
bPAB to the second-stage procedure and thus you do not require
ductal stenting. This would eliminate the potential for duct-
induced stenosis of the aortic isthmus and thereby a problem
with retrograde flow in the aortic arch.
Two questions regarding that. First, did you have any complica-
tions associated with prolonged prostaglandin infusion? Second, at
the second-stage procedure, did you see any stenosis or other an-
atomic abnormality in the isthmus?
Dr Kitahori. The reported side effects of prostaglandin have
been apnea and thickening of the periosteum of the long bone.
One patient had an apnea attack, but it was not so severe, and re-
intubation was not needed. We have never observed thickening of
the periosteum of the long bone to date. In our institute, prostaglan-
din E1 administration is considered very safe and useful for main-
taining the patent ductus arteriosus (PDA). The only problem has
been the long hospital stay. Patients receiving prostaglandin can-
not go home. At that point, a PDA stent might be superior. How-
ever, it has some problems, as you mentioned. The PDA stent
can migrate and interfere with the blood flow of the transverse
arch. It is dangerous because the blood supply to coronary artery
is also interfered. In my opinion, the frequency of complications
related to prostaglandin might be smaller than that of the PDA
stent, so we chose prostaglandin.
Dr James S. Tweddell (Milwaukee, Wis). Can I just ask 1
follow-up question to Dr Caldarone. What is the fraction of inspi-
ratory oxygen when you are doing the banding?
Dr Kitahori. Usually the fraction of inspiratory oxygen is set
at 21%.
Dr Tweddell. 21%.
Dr Kitahori. That is room air.
Dr Tweddell. And normocapnia?
Dr Kitahori. Yes.
Dr Renato S. Assad (Sao Paulo, Brazil). I just would like to
share with the Association some comments about this technique.
We have used adjustable PA bands for high-risk patients with hy-
poplastic left heart syndrome, a simple method to percutaneously
regulate the pulmonary blood flow over time. Regarding our pro-
tocol of adjusting the PA bands in the operating room, the precise
degree of banding ring constriction is adjusted after sternalgery c November 2010
Kitahori et al Congenital Heart Diseaseclosure. Because we do not have TEE for small neonates, we ask
the anesthesiologist to keep the fraction of inspiratory oxygen in
the 21% to 30% range to be able to achieve SaO2 in the low 80s
during banding adjustment. That is our straightforward protocol
for PA banding adjustment, trying to administer the same amount
of volume in both banding cuffs to achieve similar blood flow to
both lungs. This system has allowed stable SaO2 in the low 80s
throughout the interstage 1-2.
Dr Kitahori. Thank you for your comments.
Dr Hideto Shimpo (Tsu, Mie, Japan). I congratulate
Dr Kitahori on very interesting data. I have a couple of questions.
Are there any differences between the RPA groups and the LPA
groups at the Fontan procedure?The Journal of Thoracic and CarDr Kitahori. Sometimes we have seen LPA stenosis, but it has
not been so severe. We did not need PA-plasty for LPA stenosis,
but it can be a problem of this technique. The PA band can cause
PA stenosis, especially at the PA banding site. However, we have
not needed any PA-plasty so far and have just inserted a dilator
into the LPA, which has been good enough.
Dr Shimpo.My second question: I think this technique is a very
good option for complex disease, so have you applied this tech-
nique to other complex diseases, for example, truncus arteriosis
and so on?
Dr Kitahori. I think bPAB is a good option for other dis-
eases, but we have few such cases. So, I cannot comment on
that, sorry.diovascular Surgery c Volume 140, Number 5 1091
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